LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | R406 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11540 | 11155 | 1.0345 | 1.0407 |
MCF 10A | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 9923 | 11155 | 0.8896 | 0.8698 |
MCF 10A | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10005 | 11155 | 0.8969 | 0.8785 |
MCF 10A | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 1694 | 2692 | 11155 | 0.2413 | 0.1055 |
MCF 10A | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 1694 | 2367 | 11155 | 0.2122 | 0.0712 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11327 | 11155 | 1.0154 | 1.0181 |
MCF 10A | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11024 | 11155 | 0.9883 | 0.9862 |
MCF 10A | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1694 | 7707 | 11155 | 0.6909 | 0.6355 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 2233 | 11155 | 0.2002 | 0.0569 |
MCF 10A | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11282 | 11155 | 1.0113 | 1.0134 |
MCF 10A | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11015 | 11155 | 0.9874 | 0.9852 |
MCF 10A | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 10424 | 11155 | 0.9344 | 0.9227 |
MCF 10A | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10451 | 11155 | 0.9369 | 0.9256 |
MCF 10A | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11138 | 11155 | 0.9984 | 0.9981 |
MCF 10A | JNK-9L | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11450 | 11155 | 1.0264 | 1.0311 |
MCF 10A | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11170 | 11155 | 1.0013 | 1.0016 |
MCF 10A | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10844 | 11155 | 0.9721 | 0.9671 |
MCF 10A | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11145 | 11155 | 0.9991 | 0.9989 |
MCF 10A | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11701 | 11155 | 1.0489 | 1.0576 |
MCF 10A | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 10398 | 11155 | 0.9321 | 0.9200 |
MCF 10A | Mitoxantrone | 0.04 | uM | LJP5 | 72 | hr | 1694 | 3239 | 11155 | 0.2904 | 0.1633 |
MCF 10A | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 1694 | 3196 | 11155 | 0.2866 | 0.1588 |
MCF 10A | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11562 | 11155 | 1.0364 | 1.0429 |
MCF 10A | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 5640 | 11155 | 0.5056 | 0.4170 |
MCF 10A | Nilotinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11366 | 11155 | 1.0189 | 1.0222 |